These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 7862446)
1. fra-2 promoter can respond to serum-stimulation through AP-1 complexes. Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446 [TBL] [Abstract][Full Text] [Related]
2. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters. Rutberg SE; Saez E; Lo S; Jang SI; Markova N; Spiegelman BM; Yuspa SH Oncogene; 1997 Sep; 15(11):1337-46. PubMed ID: 9315102 [TBL] [Abstract][Full Text] [Related]
3. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging. Whisler RL; Chen M; Beiqing L; Carle KW Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187 [TBL] [Abstract][Full Text] [Related]
4. Activation and inhibition of the AP-1 complex in human breast cancer cells. Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858 [TBL] [Abstract][Full Text] [Related]
6. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences. Hadman M; Loo M; Bos TJ Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933 [TBL] [Abstract][Full Text] [Related]
7. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells]. Chuĭkin IA; Lianguzova MS; Pospelov VA Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838 [TBL] [Abstract][Full Text] [Related]
8. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related]
9. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types. Barrett TJ; Vedeckis WV Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052 [TBL] [Abstract][Full Text] [Related]
10. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1. Catling AD; Wyke JA; Frame MC Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932 [TBL] [Abstract][Full Text] [Related]
11. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557 [TBL] [Abstract][Full Text] [Related]
12. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488 [TBL] [Abstract][Full Text] [Related]
13. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes. Tay DL; Hoffbrand AV; Wickremasinghe GR Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1. Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237 [TBL] [Abstract][Full Text] [Related]
15. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells. Kutz SM; Providence KM; Higgins PJ Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948 [TBL] [Abstract][Full Text] [Related]
16. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells. Beiqing L; Chen M; Whisler RL J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110 [TBL] [Abstract][Full Text] [Related]
17. Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements. Adiseshaiah P; Peddakama S; Zhang Q; Kalvakolanu DV; Reddy SP Oncogene; 2005 Jun; 24(26):4193-205. PubMed ID: 15806162 [TBL] [Abstract][Full Text] [Related]
18. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development. Carrasco D; Bravo R Oncogene; 1995 Mar; 10(6):1069-79. PubMed ID: 7700631 [TBL] [Abstract][Full Text] [Related]
19. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain. Sonnenberg JL; Mitchelmore C; Macgregor-Leon PF; Hempstead J; Morgan JI; Curran T J Neurosci Res; 1989 Sep; 24(1):72-80. PubMed ID: 2553994 [TBL] [Abstract][Full Text] [Related]
20. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK. Murakami M; Ui M; Iba H Cell Growth Differ; 1999 May; 10(5):333-42. PubMed ID: 10359014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]